Introduction. Angiotensin converting enzyme inhibitors (ACE inhibitors) have recently attracted attention as a new class of drugs for the treatment of glaucoma. ACE inhibitors have been shown to lower intraocular pressure (IOP) in patients with intraocular hypertension or open-angle glaucoma due to both systemic and local haemodynamic effects. Aim of study. Aim of study was to analyse the beneficial effects of ACE inhibitors in the treatment of glaucoma and the mechanisms to prevent the progression of retinal ganglion cell degeneration. Methods and materials. The articles in the PubMed database were selected and analysed according to the keywords “renin-angiotensin system”, “glaucoma”, “angiotensin-converting enzyme”. Possible mecha...
Glaucoma is one of the world's most frequent visual impairment causes and leads to selective damage ...
Glaucoma is one of the leading causes of blindness worldwide. The main characteristic features inclu...
June Chen1, Stephen A Runyan1, Michael R Robinson21Department of Biological Sciences, 2Ophthalmology...
The clinically used sulfonamide carbonic anhydrase (CA, EC 4.2.1.1) inhibitor dorzolamide (DRZ), a n...
AbstractPurposeGlaucoma is characterized by increased intraocular pressure (IOP). The effect of nico...
Glaucoma is a slow progressive degeneration of the retinal ganglion cells (RGCs) and the optic nerve...
Prostaglandin (PG)-related ophthalmic solutions, which only recently became available for clinical u...
Based on the body of evidence implicating ocular blood flow disturbances in the pathogenesis of glau...
Glaucoma is a chronic optic neuropathy which is characterized by the loss of retinal ganglio n cell...
The history of glaucoma pharmacology begins in 1862 with the isolation of physostigmine from the cal...
Glaucoma is an optic neuropathy, considered as the second leading cause of blindness worldwide. Glau...
The definition of glaucoma has changed during past century. Traditionally glaucoma was recognized as...
BACKGROUND: Glaucoma comprises a group of neurodegenerative diseases resulting in retinal ganglion c...
These keywords were added by machine and not by the authors.International audienceGlaucoma is the le...
The renin-angiotensin system (RAS) is one of the oldest and most extensively studied human peptide c...
Glaucoma is one of the world's most frequent visual impairment causes and leads to selective damage ...
Glaucoma is one of the leading causes of blindness worldwide. The main characteristic features inclu...
June Chen1, Stephen A Runyan1, Michael R Robinson21Department of Biological Sciences, 2Ophthalmology...
The clinically used sulfonamide carbonic anhydrase (CA, EC 4.2.1.1) inhibitor dorzolamide (DRZ), a n...
AbstractPurposeGlaucoma is characterized by increased intraocular pressure (IOP). The effect of nico...
Glaucoma is a slow progressive degeneration of the retinal ganglion cells (RGCs) and the optic nerve...
Prostaglandin (PG)-related ophthalmic solutions, which only recently became available for clinical u...
Based on the body of evidence implicating ocular blood flow disturbances in the pathogenesis of glau...
Glaucoma is a chronic optic neuropathy which is characterized by the loss of retinal ganglio n cell...
The history of glaucoma pharmacology begins in 1862 with the isolation of physostigmine from the cal...
Glaucoma is an optic neuropathy, considered as the second leading cause of blindness worldwide. Glau...
The definition of glaucoma has changed during past century. Traditionally glaucoma was recognized as...
BACKGROUND: Glaucoma comprises a group of neurodegenerative diseases resulting in retinal ganglion c...
These keywords were added by machine and not by the authors.International audienceGlaucoma is the le...
The renin-angiotensin system (RAS) is one of the oldest and most extensively studied human peptide c...
Glaucoma is one of the world's most frequent visual impairment causes and leads to selective damage ...
Glaucoma is one of the leading causes of blindness worldwide. The main characteristic features inclu...
June Chen1, Stephen A Runyan1, Michael R Robinson21Department of Biological Sciences, 2Ophthalmology...